Succeed

Insulin Secretion Assays

GSIS & cAMP beta cell function assays

FUNCTIONAL AND PHYSIOLOGICAL ASSAYS VALIDATED FOR GLP-1/GIP REFERENCE COMPOUNDS

Two complementary assays using human primary-like pancreatic beta cells

KEY ADVANTAGES

GSIS BETA CELL FUNCTION GOLD STANDARD
HIGH THROUGHPUT COST-EFFECTIVE cAMP
DATA COMPARABILITY BETWEEN GSIS & cAMP
VALIDATED FOR GLP1-R & GIP-R COMPOUNDS
PHYSIOLOGICAL & TRANSLATIONAL NATIVE-LIKE MODEL

Insulin secretagogues and GLP-1 and GIP incretins regulate blood glucose by potentiating pancreatic insulin secretion. They now represent a treatment of reference for patients with type 2 diabetes. Human Cell Design proposes 2 complementary EndoC-βH5®-based assays dedicated to drug screening campaigns:

cAMP accumulation represents a rapid and cost-effective assay for fast & sensitive drug ranking for medium & high throughput screening.

Glucose Stimulated Insulin Secretion (GSIS) potentiation assay represents a direct & physiologically relevant gold standard widely recognized by academic research, for evaluation of your candidate on the beta cell function. 

GSIScAMP
ReadoutPhysiologicalPhysiological
MeasurementDirectIndirect
Throughput12 - 24 - 48 - 96 wells12 - 24 - 48 - 96 - 384 wells
CostMediumLow
SensitivityHighHigh
ResolutionHighHigh

APPLICATIONS

High resolution & translational assays for efficient compound ranking

Screen your molecules with validated references GLP1/GIP-RA compounds

Human translational assays
cAMP assay for drug discovery campaign
GSIS reference assay for preclinical studies
Physiologically relevant: endogenous GLP-1/GIP receptors expression
Robust pharmacological validation (Exendin-4, Semaglutide, Tirzepatide)
Highly reproducible standardized assay
High sensitivity (>10 fold increase)
Long-term data comparability
Chronic treatment compatible: beta cell function maintained over 4 weeks

ASSAY CONCEPT

RESULTS

Glucose Stimulated Insulin Secretion (GSIS) gold-standard functional assay

EC50 of of GLP1/GIP-receptor agonists based on dose-response of potentiation of GSIS (11mM of glucose)

GLP1-RA
GIP-RA
GLP1/GIP-RA

Physiological assay with GLP1/GIP analogs response

High sensitivity with 4-fold-increase in insulin secretion upon GLP1 reference compounds

ELISA standardized assay with high reproducibility

8 compounds/plate on 96-wells format

Rapid hightroughput & cost-effective cAMP-based assay

95% of GSIS/cAMP correlation on GLP1-R agonists ranking

HTRF standardized assay with high reproducibility

38 compounds/plate on 384-wells format

Cost effective assay for rapid screening campaign

GSIS & cAMP potency assays correlation of pEC50 means for 3 GLP-1R agonists

DOWNLOADS

Find out more about the two assays physiological and pharmacological responses

HAVE A PROJECT IN MIND?

Human Cell Design team of experts can offer you tailored assays and EndoC-βH5® derived cell models.

FIND THE RIGHT SERVICE FOR YOUR STUDY

Human Cell Design provides tailored services specifically designed for accelerating clinically relevant scientific progress in Type 1 and Type 2 diabetes research. From target validation to preclinical validation, our experts provide you with long term strategies and help you develop stables readouts and valuable deliverables.

ASSAY DEVELOPMENT

Tailored solutions for your project

Learn More
GLUCOLIPOTOXICITY

GLTx-mediated type 2 diabetes assay

Learn More
BETA CELL INFLAMMATION

Cytokine-mediated inflammation assay

Learn More